Concepedia

Author

Bahareh Kashani

Tehran University of Medical SciencesORCID

Also Known As

Bahareh Kashani, Bahareh Kashani, Kashani Bahareh

24

Publications

513

Citations

11

H-Index

24

Concepts

All Affiliations

Tehran University of Medical SciencesShariati HospitalShahid Beheshti University of Medical SciencesTurku Centre for BiotechnologyÅbo Akademi University
BK

About

Bahareh Kashani is an author at Tehran University of Medical Sciences specializing in medicine, immunology, and breast cancer.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

7

7

247

2

Immunology

6

6

229

3

Cell Biology

4

4

141

4

Pharmacology

3

3

89

5

Pathology

1

1

18

Bahareh Kashani

×

9

Publications

268

Citations

9

H-Index

YearCitations

Small molecule inhibitor of TLR4 inhibits ovarian cancer cell proliferation: new insight into the anticancer effect of TAK-242 (Resatorvid)

Bahareh Kashani, Zahra Zandi, Davood Bashash,

Cancer Chemotherapy and Pharmacology

2019

55

TLR4 blockade using TAK-242 suppresses ovarian and breast cancer cells invasion through the inhibition of extracellular matrix degradation and epithelial-mesenchymal transition

Zahra Zandi, Bahareh Kashani, Ensieh M. Poursani,

European Journal of Pharmacology

2019

54

The anticancer effect of the TLR4 inhibition using TAK‐242 (resatorvid) either as a single agent or in combination with chemotherapy: A novel therapeutic potential for breast cancer

Zahra Zandi, Bahareh Kashani, Davood Bashash,

Journal of Cellular Biochemistry

2019

38

Arsenic trioxide and BIBR1532 synergistically inhibit breast cancer cell proliferation through attenuation of NF-κB signaling pathway

Ali Nasrollahzadeh, Davood Bashash, Majid Kabuli,

Life Sciences

2020

34

Blockade of TLR4 using TAK-242 (resatorvid) enhances anti-cancer effects of chemotherapeutic agents: a novel synergistic approach for breast and ovarian cancers

Bahareh Kashani, Zahra Zandi, Mohammad Reza Karimzadeh,

Immunologic Research

2019

33

Anti-tumor activity of neratinib, a pan-HER inhibitor, in gastric adenocarcinoma cells

Sepideh Hamzehlou, Majid Momeny, Zahra Zandi,

European Journal of Pharmacology

2019

18

Toll-like receptor 4 signaling pathway is correlated with pathophysiological characteristics of AML patients and its inhibition using TAK-242 suppresses AML cell proliferation

Sedigheh Baakhlagh, Bahareh Kashani, Zahra Zandi,

International Immunopharmacology

2020

15

Cediranib, a pan-inhibitor of vascular endothelial growth factor receptors, inhibits proliferation and enhances therapeutic sensitivity in glioblastoma cells

Majid Momeny, Sahar Shamsaiegahkani, Bahareh Kashani,

Life Sciences

2021

11

Kermanian propolis induces apoptosis through upregulation of Bax/Bcl-2 ratio in acute myeloblastic leukemia cell line (NB4)

Maryam Samareh Salavatipour, Seyedeh Mehrnaz Kouhbananinejad, Mahla Lashkari,

Journal of Cancer Research and Therapeutics

2022

10

Page 1